-- U.S. RESEARCH ROUNDUP-BlackBerry, Medtronic, Idenix Pharmaceuticals   
-- 
-- Fri Jun 20, 2014 02:16AM EDT
-- None



June 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Blackberry and Medtronic, on Friday.

HIGHLIGHTS * BlackBerry <BBRY.O>: BMO raises target price to $9 from $8; rating market perform * Medtronic <MDT.N>: Jefferies raises to buy from hold * Idenix Pharmaceuticals <IDIX.O>: UBS cuts to neutral from buy rating  Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.   * BlackBerry <BBRY.O>: CIBC raises target price to $6.25 from $5 * BlackBerry <BBRY.O>: BMO raises target price to $9 from $8; rating market perform * BlackBerry <BBRY.O>: UBS raises target price to $9 from $8.50; rating neutral  * BlackBerry<BBRY.O>: Nomura raises target price to $10 from $9; rating neutral  * China Cord Blood <CO.N>: Jefferies raises price target to $6 from $5.50; rating buy * China Cord Blood <CO.N>: Roth raises target price to $6; rating buy * Coach Inc <COH.N>: Keybanc cuts price target to $46 from $55; rating buy * Coach Inc <COH.N>: Canaccord Genuity cuts target price to $35 from $42; rating hold * Coach Inc <COH.N>: Barclays cuts target price to $34 from $45; rating equal weight * Coach Inc <COH.N>: Nomura cuts target price to $45 from $50; rating buy * Conocophillips <COP.N>: Barclays raises target price to $100 from $88; rating overweight * Cvent <CVT.N>: Pacific Crest raises price target to $35 from $30; rating outperform * Enbridge Energy Partners <EEP.N>: Barclays raises target to $37 from $32; equal weight * Fedex Corp <FDX.N>: Barclays raises target price to $150 from $140; rating equal weight  * Forum Energy Technologies <FET.N>: Jefferies raises target to $35 from $32; rating hold * Gildan Activewear <GIL.N>: Canaccord Genuity raises target to $66 from $64; rating buy  * ICE <ICE.N>: UBS cuts target price to $235 from $239; rating buy  * Idenix Pharmaceuticals <IDIX.O>: UBS cuts to neutral from buy rating * IHS <IHS.N>: Deutsche Bank raises target price to $154 from $140; rating buy * IHS <IHS.N>: Barclays raises target price to $150 from $140; rating overweight  * KBR Inc <KBR.N>: Jefferies cuts target price to $30 from $33; rating buy * KBR Inc <KBR.N>: Credit Suisse cuts target price to $30 from $34; rating outperform * KBR Inc <KBR.N>: Barclays cuts target price to $31 from $35; rating overweight * Kroger Co <KR.N>: Barclays raises target price to $48 from $40; rating equal weight * Medtronic <MDT.N>: Jefferies raises to buy from hold * Medtronic <MDT.N>: Jefferies raises price target to $75 from $60  * Micron Technology <MU.O>: RBC raises target price to $38 from $34; rating outperform * Midcoast Energy Partners <MEP.N>: Barclays raises target to $23 from $22; equal weight  * Parker Hannifin <PH.N>: Credit Suisse cuts target to $144 from $148;rating outperform * Popular Inc <BPOP.O>: KBW raises target price by $5 to $39; rating outperform * Tibco Software <TIBX.O>: Barclays cuts target price to $21 from $22; rating underweight * Univest Corp <UVSP.O>: KBW raises target price by $1 to $22; rating market perform  * Ultratech <UTEK.O>: B. Riley cuts target price to $25; rating neutral